Loading clinical trials...
Loading clinical trials...
Comparison of the Analgesic Effect of an ACB (Adductor Canal Block) Using a New Suture-method Catheter vs a Standard Perineural Catheter vs a Single Bolus: A Randomized, Blinded, Controlled Study
In this study we wish to investigate the analgesic effect of the administration of 0.2% ropivacaine for an adductor canal block as repeated boluses (20 ml every 8 hours) through a new suture-method catheter or a standard perineural catheter compared with a single bolus (20 ml), in patients following primary total knee arthroplasty.
The aim of the study is to compare the clinical effects of three different administration forms for an ACB: repeated intermittent boluses through a Certa catheter (CC) versus repeated boluses through a standard catheter (through the needle) (SC) versus a single bolus (SB). Our dual hypothesis is that repeated boluses through a catheter (either Certa or standard catheter) reduces opioid consumption (primary outcome), as well as reduces pain scores, enhances ambulation and muscle strength compared with a single bolus, and that the Certa catheter is superior to a standard catheter.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Gentofte Hospital
Copenhagen, Denmark
Start Date
May 9, 2017
Primary Completion Date
April 12, 2018
Completion Date
April 12, 2018
Last Updated
May 1, 2018
153
ACTUAL participants
Initial bolus (Certa and standard catheter groups)
DRUG
Initial bolus (Single bolus group)
DRUG
Intermittent boluses (Certa and standard catheter groups)
DRUG
Intermittent boluses (Single bolus group)
DRUG
Lead Sponsor
University Hospital, Gentofte, Copenhagen
NCT07327463
NCT07432711
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions